in Nucleic Acid Therapeutics for Human Health


  • HOME
  • R & D
  • Collaborations

Research Collaborations

Hugel Inc.
Anti-scar program (OLX101) L/O and Joint Development
University of Virginia School of Medicine (Dr. J Ambati)
Age-related Macular Degeneration program (OLX301) Research Collaboration
ASTAR – IMCB(Singapore)
A*STAR(Singapore)-KHIDI(Korea) Joint Grant Call
Idiopathic Pulmonary Fibrosis (IPF) program (OLX201)
Korea Institute of Toxicology, Department of Inhalation Research
Development Collaboration for Respiratory program (IPF, OLX201)
Anti-scar program (OLX101) EU clinical trial
NCERP, National Center for Efficacy Evaluation of Respiratory Disease Product
Development Collaboration for pulmonary program
Théa Open Innovation by Laboratories Théa S.A.St
Collaboration and License Agreement for the treatment of AMD (OLX301A)